Talampanel

CAS : 161832-65-1

Ref. 3D-LGA83265

Informations sur le produit

• Nom: Talampanel
• Synonymes: (8R)-7-Acetyl-5-(4-aminophenyl)-8,9-dihydro-8-methyl-7H-1,3-dioxolo[4,5-h][2,3]benzodiazepine, (R)-(-)-1-(4-Aminophenyl)-3-acetyl-4-methyl-7,8-methylenedioxy-3,4-dihydro-5H-2,3-benzodiazepine, 1-[(8R)-5-(4-Aminophenyl)-8-methyl-8,9-dihydro-[1,3]dioxolo[4,5-h][2,3]benzodiazepin-7-yl]ethanone, 1-[(8R)-5-(4-aminophenyl)-8-methyl-8,9-dihydro-7H-[1,3]dioxolo[4,5-h][2,3]benzodiazepin-7-yl]ethanone, 7H-1,3-Dioxolo[4,5-h][2,3]benzodiazepine, 7-acetyl-5-(4-aminophenyl)-8,9-dihydro-8-methyl-, (8R)-, 7H-1,3-Dioxolo[4,5-h][2,3]benzodiazepine, 7-acetyl-5-(4-aminophenyl)-8,9-dihydro-8-methyl-, (R)-, Gyki 53773, Ly 300164
• CAS: 161832-65-1

Description

Talampanel is a drug that has been shown to be an antagonist of the AMPA-type glutamate receptor, which is important for maintaining normal cell growth and survival. Talampanel has also been shown to inhibit the activity of certain kinases, including protein kinase C (PKC) and mitogen-activated protein kinase (MAPK), which are involved in signaling pathways that regulate cell growth. Talampanel may have potential as a treatment for cancer or neurodegenerative disorders such as Alzheimer's disease.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 337.37 g/mol
• Formule: C₁₉H₁₉N₃O₃
• Degré de pureté: Min. 95%